Although the redox homeostasis disorders seem to be similar in patients with obesity and MS as well as obesity itself, cases with metabolic syndrome showed a continuous decrease in the antioxidant status (GSH, [GSH]2/[GSSG]), reduced SOD activity and an increase in UA plasma concentration. This evidence concerns the gene SOD1 and myeloid sarcoma.